Social Support Mobilization for HIV Infections

Phase-Based Progress Estimates
HIV Infections
Social Support Mobilization - Behavioral
What conditions do you have?

Study Summary

This trial will recruit 100 HIV+ men who have sex with men and compare the effects of an individual care counseling intervention to a social support mobilization intervention. The study will assess whether the social support mobilization intervention produces greater evidence of benefit on the primary outcome of medical care attendance and on secondary outcomes of having undetectable viral load, ART adherence, and psychosocial well-being.

Treatment Effectiveness

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 6 months

6 months
HIV Medical Appointments Kept
HIV Medical Appointments Missed

Trial Safety

Trial Design

2 Treatment Groups

Individual Care Counseling
1 of 2
Social Support Mobilization
1 of 2
Active Control
Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Social Support Mobilization · No Placebo Group · N/A

Social Support Mobilization
Experimental Group · 1 Intervention: Social Support Mobilization · Intervention Types: Behavioral
Individual Care Counseling
ActiveComparator Group · 1 Intervention: Individual Care Counseling · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
554 Previous Clinical Trials
1,152,072 Total Patients Enrolled
11 Trials studying HIV Infections
4,182 Patients Enrolled for HIV Infections

Eligibility Criteria

Age 18+ · Male Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 27th, 2021

Last Reviewed: October 14th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.